Mild Essential Hypertension Completed Phase 2 Trials for CYT006-AngQb (DB05739)

IndicationStatusPhase
DBCOND0036953 (Mild Essential Hypertension)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00710372Safety, Tolerability and Efficacy of a Vaccine Against Essential HypertensionTreatment